Crescent BiopharmaCBIO
13F holders, Q2 2025 (June 30)30holders
$16.14avg. 13F price*
At the end of Q2 2025, 30 institutions reported holding Crescent Biopharma Inc. (CBIO) in their 13F filings. The largest holders were FMR LLC ($22.8M), Fairmount Funds Management LLC ($22.4M) and Venrock Adviser, LLC ($22.4M).
- Company
- Crescent Biopharma Inc.
- CUSIP
- G2545C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 31 | $173.5M |
| Exits | 0 | $0 |
Ownership 30 holders
| FMR LLC | 0.00% | New | 1,414,190 | $22.8M |
| Fairmount Funds Management LLC | 2.90% | New | 1,387,866 | $22.4M |
| Venrock Adviser, LLC | 1.68% | New | 1,387,864 | $22.4M |
| BVF Inc. | 0.80% | New | 1,387,863 | $22.4M |
| Paradigm Biocapital Advisors LP | 0.44% | New | 642,721 | $10.4M |
| Logos Global Management LP | 1.19% | New | 553,686 | $8.9M |
| Boxer Capital Management, LLC | 3.69% | New | 453,686 | $7.3M |
| Commodore Capital LP | 0.52% | New | 453,686 | $7.3M |
| Perceptive Advisors LLC | 0.27% | New | 453,686 | $7.3M |
| Deep Track Capital, LP | 0.24% | New | 453,686 | $7.3M |
| Frazier Life Sciences Management, L.P. | 0.29% | New | 453,685 | $7.3M |
| Soleus Capital Management, L.P. | 0.45% | New | 400,000 | $6.5M |
| Driehaus Capital Management LLC | 0.04% | New | 302,457 | $4.9M |
| Affinity Asset Advisors, LLC | 0.70% | New | 280,031 | $4.5M |
| Braidwell LP | 0.20% | New | 261,504 | $4.2M |
| Wellington Management Group LLP | 0.00% | New | 179,886 | $2.9M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | New | 100,912 | $1.6M |
| Blackstone Inc. | 0.01% | New | 75,614 | $1.2M |
| Tang Capital Management LLC | 0.04% | New | 50,152 | $809K |
| Jefferies Financial Group Inc. | 0.01% | New | 27,096 | $437K |
| Morgan Stanley | 0.00% | New | 15,394 | $248K |
| Bank of America Corp. | 0.00% | New | 9,231 | $149K |
| BlackRock, Inc. | 0.00% | New | 6,051 | $98K |
| Barclays PLC | 0.00% | New | 286 | $5K |
| UBS Group AG | 0.00% | New | 223 | $4K |
| Group One Trading LLC | 0.00% | New | 162 | $3K |
| SBI Securities Co., Ltd. | 0.00% | New | 68 | $1K |
| Raymond James Financial Inc. | 0.00% | New | 50 | $807 |
| BNP Paribas Financial Markets | 0.00% | New | 4 | $65 |
| Royal Bank of Canada | 0.00% | New | 20 | $0 |
"% of holder's portfolio" is CBIO's weight in each manager's 13F, not the share of Crescent Biopharma Inc. the manager owns.